Oliver Gaemperli

Showing 1-3 of 3 articles

Interventions for valvular disease

Impact of aetiology of mitral regurgitation on outcome after Mitraclip: lessons learned from MitraSwiss Registry.

Sürder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger R, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G, Curti M, Moarof I, Mueller O

February 4, 2020 | 10.4244/EIJ-D-19-00718

Interventions for valvular disease

First-in-man report of residual “intra-clip” regurgitation between two MitraClips treated by AMPLATZER Vascular Plug II

Taramasso M, Zuber M, Gruner C, Gaemperli O, Nietlispach F, Maisano F

April 20, 2016 | 10.4244/EIJY14M12_04

Interventions for valvular disease

Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation

Frangieh A, Gruner C, Mikulicic F, Attinger-Toller A, Tanner F, Taramasso M, Corti R, Grünenfelder J, Lüscher T, Ruschitzka F, Bettex D, Maisano F, Gaemperli O

April 8, 2016 | 10.4244/EIJV11I14A320

1

Latest news

TAVI dysfunction, coronary sinus narrowing, carotid interventions through the snuffbox, and more

CT image showing a case of valve thrombosis after ViV TAVI

February 20, 2020

Will Your Heart Team EXCEL?

February 20, 2020

This Weeks JAA's: SAFE-A study, Coronary access after TAVR-in-TAVR and much more

February 25, 2020

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

New ahead of print: Validation of ARC-HBR criteria

February 18, 2020

New Editor-in-Chief editorial: Moving forward

Davide Capodanno

February 7, 2020

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke